Total Payments
$24,609
2024 Payments
$735.57
Companies
38
Transactions
269
Medicare Patients
335
Medicare Billing
$17,356
Payment Breakdown by Category
Other$16,750 (68.1%)
Food & Beverage$4,423 (18.0%)
Travel$2,993 (12.2%)
Education$439.74 (1.8%)
Consulting$2.41 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $13,750 | 13 | 55.9% |
| Food and Beverage | $4,423 | 208 | 18.0% |
| Honoraria | $3,000 | 1 | 12.2% |
| Travel and Lodging | $2,993 | 15 | 12.2% |
| Education | $439.74 | 25 | 1.8% |
| Consulting Fee | $2.41 | 1 | 0.0% |
| Unspecified | $0 | 6 | 0.0% |
Payments by Type
General
$24,609
263 transactions
Ownership
$0
6 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AMAG Pharmaceuticals, Inc. | $17,549 | 54 | $0 (2020) |
| Allergan Inc. | $2,586 | 33 | $0 (2019) |
| Celularity Inc. | $1,200 | 4 | $0 (2022) |
| ABBVIE INC. | $596.79 | 29 | $0 (2023) |
| Exeltis, USA Inc. | $329.21 | 17 | $0 (2024) |
| Applied Medical Resources Corporation | $245.38 | 4 | $0 (2021) |
| PFIZER INC. | $237.61 | 17 | $0 (2024) |
| Avion Pharmaceuticals | $172.28 | 11 | $0 (2023) |
| Organon Llc | $150.37 | 2 | $0 (2024) |
| TherapeuticsMD, Inc. | $147.17 | 10 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $735.57 | 29 | Exeltis, USA Inc. ($149.88) |
| 2023 | $339.57 | 17 | ABBVIE INC. ($168.35) |
| 2022 | $659.10 | 32 | Celularity Inc. ($300.00) |
| 2021 | $274.59 | 7 | Applied Medical Resources Corporation ($245.38) |
| 2020 | $172.43 | 13 | AbbVie Inc. ($55.00) |
| 2019 | $1,926 | 59 | Celularity, Inc. ($900.00) |
| 2018 | $1,530 | 44 | AMAG Pharmaceuticals, Inc. ($923.62) |
| 2017 | $18,971 | 68 | AMAG Pharmaceuticals, Inc. ($16,550) |
All Payment Transactions
269 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 11/08/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/06/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 11/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Biological | ||||||
| 10/30/2024 | Organon Llc | — | Food and Beverage | In-kind items and services | $134.94 | General |
| 10/22/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 10/08/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Biological | ||||||
| 10/08/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $7.46 | General |
| Category: CONTRACEPTIVE | ||||||
| 10/01/2024 | CooperSurgical, Inc. | Paragard T 380A (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Endocrinology | ||||||
| 09/19/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Endocrinology | ||||||
| 09/10/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: VACCINES | ||||||
| 09/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Biological | ||||||
| 09/06/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 09/05/2024 | CooperSurgical, Inc. | Endosee (Device) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Obstetrics/Gynecology (Women's Health) | ||||||
| 08/05/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: VACCINES | ||||||
| 06/24/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Biological | ||||||
| 06/13/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $121.77 | General |
| Category: CONTRACEPTIVE | ||||||
| 05/31/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Bone Health | ||||||
| 05/22/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: HORMONE THERAPY | ||||||
| 05/03/2024 | CooperSurgical, Inc. | Summit Doppler (Device) | Food and Beverage | In-kind items and services | $43.25 | General |
| Category: Devices | ||||||
| 04/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Biological | ||||||
| 04/02/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: VACCINES | ||||||
| 03/18/2024 | MILLICENT US INC | INTRAROSA (Drug), FEMRING | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 03/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Biological | ||||||
| 03/01/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $5.10 | General |
| Category: CONTRACEPTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 129 | 149 | $8,450 | $5,251 |
| 2022 | 3 | 78 | 90 | $6,820 | $4,858 |
| 2021 | 3 | 75 | 81 | $5,968 | $4,447 |
| 2020 | 2 | 53 | 58 | $3,980 | $2,801 |
Total Patients
335
Total Services
378
Medicare Billing
$17,356
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 54 | 54 | $2,970 | $2,360 | 79.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 20 | $2,200 | $1,404 | 63.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 19 | $1,520 | $727.58 | 47.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 12 | 12 | $660.00 | $589.08 | 89.3% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 32 | 44 | $1,100 | $170.04 | 15.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 34 | $3,740 | $2,269 | 60.7% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 37 | 37 | $2,035 | $1,645 | 80.8% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 19 | 19 | $1,045 | $943.72 | 90.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 22 | 28 | $3,068 | $2,003 | 65.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 41 | 41 | $2,240 | $1,838 | 82.1% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 12 | 12 | $660.00 | $605.28 | 91.7% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 38 | 38 | $1,900 | $1,719 | 90.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 15 | 20 | $2,080 | $1,082 | 52.0% |
About Dr. Daniel Ferrante, D.O
Dr. Daniel Ferrante, D.O is a Obstetrics & Gynecology healthcare provider based in Denville, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316998859.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Ferrante, D.O has received a total of $24,609 in payments from pharmaceutical and medical device companies, with $735.57 received in 2024. These payments were reported across 269 transactions from 38 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($13,750).
As a Medicare-enrolled provider, Ferrante has provided services to 335 Medicare beneficiaries, totaling 378 services with total Medicare billing of $17,356. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Other Specialties Obstetrics & Gynecology
- Location Denville, NJ
- Active Since 05/12/2006
- Last Updated 11/29/2023
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1316998859
Products in Payments
- MAKENA (Drug) $12,095
- LILETTA (Drug) $2,022
- Orilissa (Drug) $305.00
- LO LOESTRIN FE (Drug) $236.84
- SLYND (Drug) $176.60
- Veozah (Drug) $129.89
- INTRAROSA (Drug) $129.35
- Balcoltra (Drug) $116.28
- PREMARIN (Drug) $115.65
- Vitafol Ultra (Drug) $110.40
- MYFEMBREE (Drug) $82.26
- Prolia (Biological) $76.41
- IMVEXXY (Drug) $72.52
- DIVIGEL (Drug) $64.09
- PREMARIN ORALS (Drug) $62.00
- CORVITE FE W QUATREFOLIC (Drug) $60.16
- ZURZUVAE (Drug) $56.94
- ORILISSA (Drug) $55.00
- FEMRING (Drug) $54.98
- Osphena (Drug) $52.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Denville
Dr. Cem Omay, M.d, M.D
Obstetrics & Gynecology — Payments: $6,463
Obstetrics & Gynecology $6,463
Jennifer Agnello, Do, DO
Obstetrics & Gynecology — Payments: $3,447
Obstetrics & Gynecology $3,447
Dr. Richard Rothenberg, M.d, M.D
Obstetrics & Gynecology — Payments: $2,847
Obstetrics & Gynecology $2,847
Dr. Manfred Strott, Md, MD
Obstetrics & Gynecology
Obstetrics & Gynecology